Abbott Laboratories (abt)
ABT Valuation
| P/E (trailing) | 34.27 |
| P/E (forward) | 17.81 |
| EV/EBITDA | 18.37 |
| Price/Sales | 4.04 |
| Price/Book | 3.66 |
| Market cap | $188.05B |
Abbott Laboratories FAQ
What does Abbott Laboratories (ABT) do?
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers…
What is ABT's P/E ratio?
Abbott Laboratories has a trailing P/E of 34.27× based on publicly available market data.
Does ABT pay a dividend?
Indicated dividend yield: 2.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is ABT in?
Abbott Laboratories is classified in Healthcare (Medical Devices) on NYQ.
What is ABT's market capitalization?
Approximate market cap: $188.05B.
What are the main risks for ABT?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of ABT?
Potential positives include revenue growth of 13.0% year-over-year, gross margin of 56.8% supports competitive unit economics.
Where can I get analyst estimates for ABT?
Consensus estimates, price targets, and detailed analyst data for Abbott Laboratories are available to Professional subscribers in Vest Terminal — not on this public summary page.